Since 2021, the pandemic preparedness and response (PPR) landscape has meaningfully changed. Emergency responses to COVID-19 have tapered down as populations have been vaccinated. Funding for PPR research and development (R&D) is waning. Progress on the 100 Days Mission has been made, however, momentum must be maintained to ensure effective countermeasures are in place for the next pandemic. This report highlights several key areas that require attention in 2023 to reduce the impact of future pandemic threats. This will involve leadership and coordination from the G7, G20, IPPS and WHO to ensure a collaborative effort across all stakeholders.
Key recommendations:
- Coordinate R&D against priority virus families.
- Advance programmable platform technologies for vaccines and therapeutics.
- Integrate global diagnostic R&D and surveillance efforts.
- Accelerate clinical trial and regulatory processes for data generation.
- Build sustainable, regional DTV manufacturing capacity.
- Agree on ‘Day 0’ surge financing mechanisms.